行情

PACB

PACB

太平洋生物科学
NASDAQ

实时行情|Nasdaq Last Sale

3.280
-0.290
-8.12%
盘后: 3.280 0 0.00% 16:41 03/27 EDT
开盘
3.370
昨收
3.570
最高
3.500
最低
3.170
成交量
107.31万
成交额
--
52周最高
7.50
52周最低
2.200
市值
5.02亿
市盈率(TTM)
-5.9377
分时
5日
1月
3月
1年
5年

分析师评级

5位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测PACB价格均价为6.00,最高价位7.00,最低价为5.00。

EPS

PACB 新闻

更多
  • 大众CEO迪斯:每周损失20亿欧元 除中国市场外无收入
  • 21世纪经济报道 · 1小时前
  • 美国医用防护物资短缺 特朗普:波音、福特也要造呼吸机!
  • 环球网 · 1小时前
  • 朝“虑”夕改 特朗普称没必要对纽约等三州进行隔离
  • 央视 · 2小时前
  • 澳大利亚专家反思:应该更早对美国实施边境禁入
  • 央视 · 2小时前

所属板块

先进医疗设备和技术
-2.20%
医疗设备和用品
-1.86%

热门股票

代码
价格
涨跌幅

PACB 简况

Pacific Biosciences of California, Inc. designs, develops and manufactures sequencing systems to help scientists resolve genetically complex problems. The Company is engaged in the development, manufacturing and marketing of an integrated platform for genetic analysis. Its Single Molecule, Real-Time (SMRT) technology enables single molecule, real-time detection of biological processes. It offers The SMRT Cell, Phospholinked nucleotides and The PacBio RS II and Sequel instruments. Its SMRT technology enables the observation of deoxyribonucleic acid (DNA) synthesis as it occurs in real-time by harnessing the natural process of DNA replication, which is actuated by the DNA polymerase. Its phospholinked nucleotides have a fluorescent dye attached to the phosphate chain of the nucleotide rather than to the base. The PacBio RS II and Sequel instruments include optics, automated liquid handling, a touchscreen control interface and computational hardware and software.
展开

微牛提供Pacific Biosciences of California(NASDAQ-PACB)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的PACB股票新闻,以帮助您做出投资决策。